학술논문
LBA19 Event-free survival (EFS) analysis of neoadjuvant taxane/carboplatin with or without atezolizumab followed by an adjuvant anthracycline regimen in high-risk triple negative breast cancer (TNBC): NeoTRIP Michelangelo randomized study
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1258-S1259
Subject
Language
ISSN
0923-7534